3-(4-Benzyloxy-3-methoxyphenyl)-4-(4-chlorophenyl)-1,2,4-triazoline-5-thione, 95%, 2g

N-Methyl-(3-piperidin-1-yl-propyl)amine, 95.0%, 100mg

4-Carboxymethyl-piperazine-1-carboxylic acid benzyl ester, 95.0%, 1g

1-Phenylbuta-2,3-dien-1-one, 97%, 250mg

4',6,7-Trihydroxyisoflavone>95.0%(HPLC)(T)1g

4,6-Dichloro-2-methylpyrido[3,4-d]pyrimidine, 95.0%, 1g

(11bR)-2,6-Bis(4-chlorophenyl)-4-hydroxydinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4-oxide, 97%, 50mg

Syringe filters Minisart® NML with CE marking Sterile (gamma-sterilised), 0,45 µm, 50 Piece(s)

1-Bromo-2-(bromomethyl)naphthalene, 96.0%, 25g

4-Bromo-2-chloro-5-nitroaniline, 95.0%, 5g

Hexabromobenzene>99.0%(GC)500g

tert-Butyl ((2S,4S,5S)-5-(2-(2,6-dimethylphenoxy)acetamido)-4-hydroxy-1,6-diphenylhexan-2-yl)carbamate, 97%, 100mg

Tert-butyln-[3-(trifluoromethyl)-1-bicyclo[1.1.1]pentanyl]carbamate, 98%, 10g